Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

World Anterior Uveitis Therapeutics Report 2016: Pipeline Review of 5 Companies & 6 Molecules - Research and Markets

Research and Markets
Posted on: 12 Oct 16

Research and Markets has announced the addition of the "Anterior Uveitis - Pipeline Review, H2 2016" report to their offering.

Anterior Uveitis pipeline therapeutics constitutes close to 6 molecules

Out of which approximately 6 molecules are developed by Companies. Our latest report Anterior Uveitis - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Anterior Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Anterior Uveitis Anterior uveitis is an inflammation of the middle layer of the eye, which includes the iris (colored part of the eye) and ciliary body. Symptoms include a red, sore and inflamed eye, blurring of vision, sensitivity to light and a small pupil. The molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 3 and 2 respectively.

Furthermore, this report also reviews of key players involved in therapeutic development for Anterior Uveitis and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Anterior Uveitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Anterior Uveitis - Overview
  5. Pipeline Products for Anterior Uveitis - Comparative Analysis
  6. Anterior Uveitis - Therapeutics under Development by Companies
  7. Anterior Uveitis - Therapeutics under Investigation by Universities/Institutes
  8. Anterior Uveitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Anterior Uveitis - Products under Development by Companies
  13. Anterior Uveitis - Products under Investigation by Universities/Institutes
  14. Anterior Uveitis - Companies Involved in Therapeutics Development
  • Aciont Inc.
  • Aldeyra Therapeutics, Inc.
  • EyeGate Pharmaceuticals, Inc.
  • KPI Therapeutics, Inc.
  • Neuroptis Biotech

For more information about this report visit

View source version on

Business Wire

Last updated on: 12/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.